DWJ1248

DRUG2 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

Covid19HealthySARS-COV-2 Infection

Phase 1

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

CompletedNCT04782505

Daewoong Pharmaceutical Co. LTD.Healthy

Start: 2021-03-12End: 2021-06-28Updated: 2022-12-05

Phase 3

A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

TerminatedNCT04721535

Daewoong Pharmaceutical Co. LTD.Covid19, SARS-COV-2 Infection

Start: 2021-06-07End: 2021-10-06Updated: 2022-12-07